Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in ...
“For the second quarter of 2026, we are estimating revenues of $970 million to $1 billion, net income of $8 million to $13.7 million, adjusted EBITDA of $85 million to $95 million and adjusted EBITDA ...
More efficient use of lumber byproducts leads to more sustainable forest management. That's why Michigan Technological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results